The Use of Amantadine in the Prevention of Progression and Treatment of COVID-19 Symptoms
Status:
Recruiting
Trial end date:
2022-05-31
Target enrollment:
Participant gender:
Summary
The use of amantadine in the prevention of progression and treatment of COVID-19 symptoms in
patients infected with the SARS-CoV-2 virus. Multicenter randomized, double-blind,
placebo-controlled, non-commercial clinical trial
Phase:
Phase 3
Details
Lead Sponsor:
Independent Public Clinical Hospital No. 4 in Lublin